Ventricular tachycardia and ventricular fibrillation

Komandoor Srivathsan, Daniel W.C. Ng, Farouk Mookadam

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Ventricular tachycardia and ventricular fibrillation are the most important causes of sudden cardiac death (SCD), particularly in those with structural heart disease and reduced left ventricular function. It is important to distinguish ventricular tachycardia from supraventricular tachycardia. A wide spectrum of ventricular arrhythmias exists, from those where the heart is structurally normal to those with structural heart disease. Each entity has a distinctive pathophysiology, treatment plan and prognostic outcome. Treatment modalities include simple b-blockade to implantation of implantable cardiac defibrillator and ablative approaches. In general, those ventricular arrhythmias associated with a structurally normal heart are more benign than those associated with structural heart disease.

Original languageEnglish (US)
Pages (from-to)801-809
Number of pages9
JournalExpert Review of Cardiovascular Therapy
Issue number7
StatePublished - Jul 2009


  • Ablation
  • Antiarrhythmic drug
  • Implantable defibrillator
  • Ischemic heart disease
  • Nonischemic heart disease
  • Structural heart disease
  • Sudden cardiac death
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Ventricular tachycardia and ventricular fibrillation'. Together they form a unique fingerprint.

Cite this